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Other cells that are capable of synthesizing apoE include 
macrophages, astrocytes, and endocrine cells such as adre-
nal and ovarian cells ( 2–4 ). In addition, adipocytes have 
the capacity to synthesize signifi cant amounts of apoE, as 
fi rst reported by Zechner et al. ( 5 ). Adipocyte expression 
of apoE modulates adipocyte TG turnover, gene expres-
sion, and VLDL metabolism ( 6–8 ) in an isoform-depen-
dent manner ( 9 ). Further, adipocyte expression of apoE is 
subject to regulation by a number of physiologically rele-
vant stimuli such as organismal nutritional status ( 10 ), in-
fl ammatory cytokines ( 11 ), and adipose tissue oxidative 
stress ( 12, 13 ). 
 Global knockout of apoE in mice results in massive hy-
percholesterolemia and accelerated atherosclerosis. Both 
of these can be attenuated by bone marrow transplanta-
tion furnishing macrophages synthesizing apoE ( 14, 15 ). 
Similar observations have been made in  Apoe   /   animals 
transgenically expressing low levels of adrenal apoE ( 16, 
17 ). On the other hand, we have recently shown that wild-
type adipose tissue transplanted into  Apoe   /   mice achieves 
a plasma level of apoE similar to bone marrow transplanta-
tion (about 1% of normal), yet is unable to suppress the 
hypercholesterolemia and atherosclerosis of the  Apoe   /   
mouse ( 18 ). While the reasons for the lack of impact of 
adipose-derived apoE on circulating lipid levels remains to 
be determined, it is clear that apoE produced by adipo-
cytes is critically important for maintaining adipocyte dif-
ferentiated function ( 6–9, 19 ). 
 Animals globally defi cient in apoE are not readily ren-
dered obese by the feeding of obesogenic diets ( 20 ). Adi-
pocytes isolated from  Apoe   /   mice are smaller, store fewer 
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Lab, Bar Harbor, ME) to obtain a C57BL/6 background. Second, 
aP2-Cre transgenic mice [B6.Cg-Tg (Fabp4-Cre 1Rev/J), C57BL/6 
background, Jackson Lab] were crossed with  Apoe fl oxed homo-
zygous mice ( Apoe fl ox/fl ox ). aP2-Cre  Apoe fl ox/+ offspring were crossed 
again with  Apoe fl ox/fl ox to obtain aP2-Cre  Apoe fl ox/fl ox mice that are 
referred to as SEKO mice. Mouse genotype was confi rmed by 
PCR using both  Apoe fl ox and Cre primer sets. SEKO mice were 
born with the expected Mendelian frequency.  Apoe fl ox/+ or  Apoe +/+ , 
with or without aP2-Cre, had similar metabolic characteristics 
and were used as control mice. Mice were housed under patho-
gen-free conditions, controlled light-dark cycle (12 h/12 h), and 
free access to water and standard chow food. For measuring food 
intake, fi ve male mice of each genotype (8–10 weeks old) were 
housed individually and food was weighed daily over fi ve consec-
utive days. All animal protocols were approved by the Institu-
tional Animal Care and Use Committees of the University of 
Illinois at Chicago. 
 Tissue sampling 
 Liver, heart, gastrocnemius muscle, and a portion of epididy-
mal fat pad were fl ash frozen in liquid nitrogen when mice were 
euthanized. Tissue lipids were extracted with chloroform:methanol 
(2:1) from 20–100 mg tissue lysates. 
 Isolation and culture of adipocytes, adipocyte size, and 
number analysis 
 Freshly isolated mature adipocytes and cultured adipocytes 
were prepared as described previously ( 6–8 ). Briefl y, mature adi-
pocytes were isolated from epididymal adipose tissues by collage-
nase digestion. After centrifugation, fl oating mature adipocytes 
were collected from the top phase. The pellets of stromovascular 
cells (SVCs) that contained preadipocytes were washed and cul-
tured for 10–14 days before being used for experiments. The size 
of freshly isolated mature adipocytes was analyzed using an auto-
mated program, CCAP (Mayo Clinic, Rochester, MN). Adipocyte 
cellular lipids were estimated based on adipocyte volume and the 
density of triolein. Adipocyte cell numbers were estimated using 
a conversion factor of 6.6 pg genomic DNA per single cell ( 22 ) 
 TG synthesis rate in adipocytes 
 TG synthesis was measured as described previously ( 8 ). Freshly 
isolated and cultured adipocytes were incubated with 0.5   Ci/ml 
[ 14 C]glucose, with or without 100   g/ml human VLDL, in 0.1% 
BSA and DMEM for 6 h at 37°C. After washing, cellular lipids 
were extracted with chloroform:methanol (2:1), and TGs were 
separated by thin layer chromatography in a solvent system of 
hexane:ethyl ether:acetic acid (90:30:1). The TG spots were har-
vested and the radioactivity in the spots was measured in a scintil-
lation counter. Human VLDL was prepared from plasma of E3/
E3 donors by sequential density gradient ultracentrifugation. 
The TG synthesis rate was normalized to DNA amount or cell 
protein. 
 mRNA quantitation by quantitative RT-PCR 
 Total RNA was extracted using Qiagen kits (Valencia, CA). 
First-strand cDNA was synthesized from 1 mg total RNA accord-
ing to the manufacturer’s instructions (Fermentas, Hanover, 
MD). Real-time PCR was performed using the Mx3000p quantita-
tive PCR system (Stratagene, La Jolla, CA). Reactions were car-
ried out in a total volume of 25   l using Brilliant SYBR Green 
QRT-PCR Master Mix (Stratagene). Relative quantitation for 
each gene (expressed as fold changes over control) was calcu-
lated after normalization to   -actin. The primer pairs used for 
this study are provided in previous publications ( 6–13 ) or in a 
subsequent paragraph. 
lipids, and acquire lipids from extracellular VLDL less ef-
fi ciently than wild-type adipocytes ( 6–8 ). ApoE-defi cient 
adipocytes also have lower TG synthetic rates, and an 
increased TG hydrolysis rate ( 6–8 ). The culture of apoE-
defi cient adipocytes in media containing exogenous 
apoE-rich VLDL does not reverse the disturbances of adi-
pocyte lipid homeostasis, but viral-mediated induction of 
endogenous adipocyte apoE expression does restore a 
more normal adipocyte phenotype ( 6 ). Consistent with 
this, apoE-defi cient adipose tissue and adipocytes retain 
an abnormal phenotype after transplantation into wild-
type hosts, where they are exposed to normal circulating 
extracellular levels of apoE ( 7 ). 
 While study of isolated adipocytes and transplanted adi-
pose tissue points to the critical importance of endoge-
nous adipocyte apoE for adipocyte lipid metabolism and 
gene expression, it does not provide information regard-
ing potential changes in whole body energy homeostasis 
that might occur as a result of either altered lipid fl ux 
through adipose tissue or changes in adipokine gene 
expression that occur with reduced adipose tissue apoE 
expression ( 6–8 ). Further, interpretation of results of ex-
periments using adipose tissue transplanted between wild-
type mice and globally defi cient apoE mice are confounded 
by the exposure of adipose tissue to a markedly hyperlipid-
emic in vivo environment, either before or after transplan-
tation ( 18 ). Obtaining additional insight into the function 
of apoE expressed in adipose tissue is best approached by 
the selective suppression of apoE expression in adipo-
cytes/adipose tissue, with preserved expression in other 
tissues, particularly the liver, which accounts for over 90% 
of circulating apoE ( 1 ). In the current study, we report 
results of experiments employing a new mouse model with 
selective suppression of adipocyte and adipose tissue apoE 
with normal circulating levels of apoE 
 METHODS 
 Materials 
 Cell culture medium and FBS were purchased from Invitrogen 
(Carlsbad, CA). Organic solvents were from Thermo-Fisher 
(Pittsburgh, PA). Other chemicals were from Sigma (St. Louis, 
MO). [ 14 C]glucose was obtained from PerkinElmer (Wellesley, 
MA). Total cholesterol (TC) and TG assay kits were obtained 
from Wako Chemicals USA (Richmond, VA). Mouse insulin 
ELISA kits were purchased from ALPCO Diagnostics (Salem, 
NH). Blood glucose was measured by Alpha TRACK glucome-
ter (Abbott, Abbott Park, IL) or Infi nity glucose hexokinase 
(Thermo Fisher, Waltham, MA). Other reagents were from previ-
ously identifi ed sources ( 6–13, 18 ). The homeostatic model as-
sessment of insulin resistance (HOMA-IR) was calculated from 
fasting glucose and insulin levels as previously described ( 21 ). 
 Generation of selective adipose tissue apoE knockout 
mice 
 Selective adipose tissue  Apoe knockout (SEKO) mice were gen-
erated in two major steps. First,  Apoe exon 3 was fl anked with 2 
loxP sites in 129/SvEv mice.  Apoe “fl oxed” mice were then inten-
sively bred (10 times) with wild-type C57BL/6J mice (Jackson 
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cytometer (Beckman Coulter, Fort Collins, CO) using Summit 
4.3 software (Beckman Coulter). F4/80 + CD11b + CD11c + CD206    
or F4/80 + CD11b + CD11c    CD206 + are referred to as M1 or M2 
macrophages, respectively. Cell viability was measured with prop-
idium iodide staining of DNA fragmentation. The macrophage 
cell number was normalized to fat weight. 
 The ATM infl ammatory state was also examined by quantita-
tive (q)RT-PCR to evaluate macrophage gene expression using 
the following primer sets: CD11c forward (F) ccccagaggctgtgaacata, 
reverse (R) ttgctttggacactcctgct; TNF  F gtccccaaagggatgagaag, 
R cacttggtggtttgctacga; MCP F agctctctcttcctccacca, R ctggtgatc-
ctcttgtagctctc; IFN-  F ctcttcctcatggctgtttc, R gtcaccatccttttgccagtt; 
CD206 F GGGCTTACGGTGAACCAAAT, R TGTCTTGTGGAG-
CAGGTGTG; IL-10 F CTGGACAACATACTGCTAACCG, R GGG-
CATCACTTCTACCAGGTAA; Arg1 F tggcttgcgagacgtagac, R gct-
caggtgaatcggcctttt; iNOS F TTCCATGCTAATGCGAAAGG, R 
GCTCCTCTTCCAAGGTGCTT; YM1 F GCCCACCAGGAAAG-
TACACA, R TGTTGTCCTTGAGCCACTGA. 
 Lipid, protein, and DNA estimation 
 TC and TG levels were estimated with Wako TC and TG kits. 
Protein levels were quantifi ed with Bio-Rad protein DC kit (Bio-
Rad, Hercules, CA). DNA was isolated with a Qiagen DNeasy kit 
according to the manufacturer’s instructions and the amount of 
DNA was measured by a PicoGreen DNA assay kit (Invitrogen). 
 ApoE protein expression by Western blot 
 Samples were prepared for Western blot analysis of apoE as 
described in detail in previous publications ( 6–8 ). Western blot 
images were quantitated using ImageQuant TL software (GE 
Healthcare). 
 Glucose tolerance test and insulin tolerance test 
 SEKO or control mice were fasted for 5 h before testing, and 
were injected intraperitoneally with 1 g/kg D-glucose or 0.8 U/
kg insulin. Blood samples were collected from the tail veins at 0, 
15, 30, 60, and 120 min after injection. Glucose levels were mea-
sured by Alpha TRACK glucometer. Area under the curve (AUC) 
was calculated using Sigmaplot 11.0 (Systat, San Jose, CA). 
 Analysis of adipose tissue macrophage number and 
activation state 
 SVC fractions of adipose tissue digests that contained adipose 
tissue macrophages (ATMs) were prepared as described above. 
For fl ow cytometry analysis, red blood cells were lysed with BD 
Pharm Lyse TM for 5 min, nonspecifi c binding sites were blocked 
by incubation of cells with anti-CD16/32 antibodies for 15 min 
on ice. ATMs were stained with eFluro450-F4/80, Alexa 
488-CD11b, PE-CD11c, or Alexa 647-CD206, or their matching 
isotype control for 30 min (all antibodies were purchased from 
eBiosciences). Stained cells were analyzed with a Cyan ADP fl ow 
 Fig.  1. Generation of SEKO mice. A: Schematic representation of the  Apoe targeted allele and Cre-loxP-mediated deletion of exon 3. B: 
PCR analysis of  Apoe deletion in adipocytes of SEKO or control mice. 2F primer, ctg ttg gtc aca ttg ctg ac; 4R primer, ttg cgt aga tcc tcc atg 
tc. 
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 Fig.  2. ApoE protein and mRNA levels in SEKO and control mice. ApoE mRNA levels in whole adipose tissue, freshly isolated adipocytes, 
SVCs, and livers of SEKO or control mice were measured by qRT-PCR; apoE protein expression in whole adipose tissue, freshly isolated adi-
pocytes, mouse peritoneal macrophages (MPMs), livers, and plasma were examined by Western blot as described in the Methods. Results 
are the mean ± SD of fi ve mice (except for plasma, n = 12) per group [male, 8 weeks old (wo), or 12 wo as indicated]. * P < 0.05; ** P < 0.01 
for the difference between control and SEKO mice. 
 TABLE 1. Phenotypic characteristics of 8-week-old SEKO mice 
Control SEKO 
BW (g) 23.9 ± 1.5 21.3 ± 3.2
WAT/BW (%) 1.63 ± 0.20 1.25 ± 0.25 a 
Plasma TC (mg/dl) 110.7 ± 7.6 91.3 ± 14.5 a 
Plasma TG (mg/dl) 61.5 ± 11.4 57.0 ± 9.4
Glucose (mg/dl) 267.0 ± 25.2 195.8 ± 43.6 a 
Insulin (pg/ml) 732.5 ± 197.0 490.4 ± 117.3 a 
HOMA-IR 10.8 ± 3.8 5.1 ± 1.4 a 
Data shown are mean ± SD.
 a P < 0.05 for the difference between control and SEKO mice.
 Statistics 
 Results are expressed as the mean ± SD of fi ve mice in each 
experimental group, unless otherwise indicated in the fi gure leg-
end. Results are representative of two separate experiments. Sta-
tistical differences were analyzed using Student’s  t -test or ANOVA 
(PASW 18.0; IBM SPSS, Armonk, NY) followed by a post hoc test 
for multiple comparisons.  P < 0.05 was considered signifi cant. 
 RESULTS 
 For the construction of the selective knockout of  Apoe , 
loxP sites were inserted into either side of the third exon 
of the  Apoe gene. The fl oxed mice were initially created 
in the 129/SvEv strain and these were then backcrossed 
into the C57BL/6 background (10 generations). With the 
crossing of this strain with aP2-Cre, the knockout allele 
was established in adipocytes and macrophages, the two 
cell types in which aP2 is highly expressed ( 23 ). The pres-
ence of the knockout allele in adipocytes of SEKO mice 
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from fat pads was actually increased in the SEKO mice 
( Fig. 3A ). There was also no difference in the number of 
SVCs. However, as shown in  Fig. 3B , reduction of adipo-
cyte size and lipid content in adipocytes isolated from 
SEKO mice contributed to reduction in overall adipose 
tissue mass. 
 Table 2 presents the results of a metabolic evaluation of 
control and SEKO mice at 12–13 weeks of age. The differ-
ences between SEKO and control animals at 12–13 weeks 
were similar to those observed at 8 weeks with respect to 
BW, white adipose tissue (WAT)/BW, TC, glucose, insu-
lin, and HOMA-IR. At 12–13 weeks, plasma TG was also 
signifi cantly lower in SEKO mice. The results in  Fig. 4 
 demonstrate that at 12–13 weeks, adipocytes isolated from 
SEKO mice remain signifi cantly smaller with fewer lipids 
than those isolated from control mice. 
 To explore a potential basis for the reduced lipid con-
tent of SEKO adipocytes, we evaluated the rate of TG syn-
thesis from radioactive glucose precursor under basal 
conditions and in the presence of added apoE3-contain-
ing VLDL ( Fig. 5 ). TG synthesis was reduced in both 
freshly isolated mature and cultured SEKO adipocytes in 
both experimental conditions. The addition of apoE-con-
taining VLDL to control adipocytes leads to marked stimu-
lation of adipocyte TG synthesis. In contrast, addition of 
apoE-containing VLDL to SEKO adipocytes has no stimu-
latory impact on adipocyte TG synthesis. As a consequence, 
TG synthesis was more markedly reduced in SEKO adipo-
cytes in the presence of VLDL. 
 We have previously described changes in the expression 
of several important genes in adipocytes isolated from 
 Apoe   /   mice ( 7 ). These results, however, may have been 
infl uenced by the exposure of these adipocytes during 
their development to the markedly hyperlipidemic envi-
ronment characteristic of  Apoe   /   mice.  Figure 6  shows 
the differences in gene expression between freshly iso-
lated mature adipocytes from control and SEKO male ani-
mals at 8 weeks of age. The expected reduction in apoE 
was indicated by the 900 bp PCR product on agarose gel; 
its position is indicated in  Fig. 1A, B . This is in contrast to 
the functional allele which is 1,500 bp in length using the 
same primers. 
 The effi cacy of the selective excision of exon 3 on apoE 
expression in these animals is indicated in  Fig. 2 , where we 
show the levels of apoE mRNA and apoE protein. ApoE 
mRNA was reduced by 56% in the epididymal fat pad, by 
75% in freshly isolated mature adipocytes, and by 41% in 
SVCs, which contain the ATMs. ApoE protein levels were 
reduced 31% in the epididymal fat pad, by 81% in freshly 
isolated adipocytes, and by 55% in the peritoneal macro-
phages from these animals. The difference between the 
81% reduction of apoE protein in adipocytes compared 
with the more modest 31% reduction in the whole epi-
didymal fat pad is likely accounted for by infi ltration of the 
fat pad by circulating plasma apoE. There were no changes 
in liver apoE mRNA or protein levels in the SEKO animals. 
Plasma apoE levels were not signifi cantly different com-
paring control and SEKO mice at both 8 and 12 weeks of 
age. There was no difference in apoE mRNA expression in 
the adrenal cortex or brain comparing control to SEKO 
mice (not shown). 
 In  Table 1 important phenotypic features of 8-week-old 
control and SEKO animals are shown. Total body weight 
(BW) was not signifi cantly altered, though it trended 
lower in SEKO animals. The ratio of epididymal fat pad 
weight to BW was signifi cantly reduced in SEKO mice. Cir-
culating TG levels trended lower, but were not signifi cantly 
different between control and SEKO mice. Plasma TC, 
glucose, insulin, and HOMA-IR were all signifi cantly lower 
in SEKO mice. Food intake measured over fi ve consecu-
tive days was not different between control and SEKO 
mice (3.7 ± 0.4 g/day vs. 3.6 ± 0.4 g/day,  P = NS). 
 We next explored the basis for the reduction of adipose 
tissue mass in SEKO mice. The reduction in the ratio of 
adipose tissue weight to total BW was not attributable to a 
reduction in adipocyte number. The number of adipocytes 
 Fig.  3. Adipocyte number and size at 8 weeks. Mature adipocytes and SVCs were isolated from visceral adipose tissue of SEKO or control 
mice as described in the Methods. A: Adipocyte and SVC number was estimated as described in the Methods. B: Mature adipocyte size and 
lipid content were analyzed using CCAP software as described in the Methods. Results are the mean ± SD of fi ve mice. * P < 0.05; ** P < 0.01 
for the difference between control and SEKO mice. 
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DGAT2 mRNA expression level in the adipose tissue of 
control compared with SEKO mice (not shown). We also 
evaluated expression of several hepatic genes involved in 
TG synthesis or fatty acid oxidation. There were no differ-
ences in the levels of Dgat1, Dgat2, CPT-1, LCAD, or FASn 
between control and SEKO mice (not shown). 
 Plasma glucose, insulin, and HOMA-IR were all signifi -
cantly lower in the SEKO mice ( Tables 1, 2 ), and adipo-
cyte gene expression was altered in a manner consistent 
with higher systemic insulin sensitivity. To further explore 
a potential difference in systemic glucose homeostasis, we 
performed intraperitoneal glucose and insulin tolerance 
tests ( Fig. 7 ). The upper panels of the fi gure show the time 
course of glucose excursions after injection of a glucose 
load (on the left) or of insulin (on the right). The bottom 
panels present the AUC for each time course. Both glu-
cose tolerance and insulin effi cacy were signifi cantly bet-
ter in the SEKO mice. 
 The improved glucose tolerance and increased insulin 
sensitivity we measured in SEKO mice was unexpected. We 
therefore next evaluated potential pathways that could 
contribute to improved systemic substrate utilization. 
Changes in skeletal muscle or hepatic lipid content have 
been suggested as important markers of, or contributors 
to, the altered insulin sensitivity that occurs in response to 
fat feeding of animals or obesity in humans ( 24–28 ). We 
therefore evaluated the impact of reduced adipose tissue 
apoE expression on systemic tissue lipid distribution in 
adipose tissue, liver, skeletal muscle, and heart. TG mass 
was reduced in all four tissues ( Fig. 8 ) in SEKO mice, while 
TC mass was also reduced in all except the skeletal muscle, 
where there was a signifi cant increment in TC mass. 
 Recent information also points to an important role for 
macrophage infi ltration and infl ammatory activation in adi-
pose tissue for producing many of the systemic metabolic 
effects of obesity, including adverse changes in insulin sen-
sitivity ( 29–35 ). ApoE is expressed in both adipocytes and 
macrophages present in adipose tissue, and SEKO animals 
exhibited reduced apoE expression in both cell types, with 
more marked suppression in adipocytes ( Fig. 2 ). We next 
evaluated the impact of this reduction on adipose tissue in-
fl ammatory state by measuring the number and infl amma-
tory state of ATMs ( Fig. 9 ). The total number of ATMs was 
not different comparing control and SEKO adipose tissue. 
However, the balance between infl ammatory (M1) and non-
infl ammatory (M2) macrophages was signifi cantly altered 
gene expression is demonstrated. Even without previous 
exposure to a hyperlipidemic environment, signifi cant 
changes in gene expression were evident. Caveolin and 
leptin expression were signifi cantly decreased in SEKO 
adipocytes. Adiponectin, PGC-1, and CPT-1 expression 
were signifi cantly increased, while there was no change in 
ACO and ACADM. The changes in adipocyte leptin ex-
pression (lower) and adiponectin expression (higher) 
were consistent with the differences in adipocyte cell size 
noted in  Fig. 3 for SEKO compared with control adipo-
cytes. There was also no difference in the DGAT1 or 
 TABLE 2. Phenotypic characteristics of 12–13-week-old SEKO mice 
Control SEKO
BW(g) 25.8 ± 2.8 25.1 ± 0.6
WAT/BW (%) 1.22 ± 0.15 1.01 ± 0.10 a 
Plasma TC (mg/dl) 114.0 ± 3.8 96.1 ± 5.1 a 
Plasma TG (mg/dl) 78.6 ± 14.8 53.2 ± 8.9 a 
Glucose (mg/dl) 176.2 ± 9.3 153.5 ± 5.8 a 
Insulin (pg/ml) 736.3 ± 77.7 574.8 ± 52.2 b 
HOMA-IR 7.0 ± 0.6 4.8 ± 0.5 b 
Data are represented as mean ± SD.
 a P < 0.05.
 b P < 0.01 for the difference between control and SEKO mice.
Fig.  3. Continued.
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 Fig.  4. Adipocyte size at 12–13 weeks. Mature adi-
pocyte size and lipid content were analyzed using 
CCAP software as described in the Methods. Results 
are the mean ± SD of fi ve mice. * P < 0.05 for the dif-
ference between control and SEKO mice. 
in the SEKO adipose tissue; with the latter having a pre-
dominance of the noninfl ammatory phenotype (upper 
panels). Consistent with this fl ow cytometric data, pro-
infl ammatory gene expression was signifi cantly higher in 
control compared with SEKO ATMs, while anti-infl amma-
tory gene expression was signifi cantly higher in the SEKO 
ATMs (lower panels). These results establish a less infl am-
matory phenotype in SEKO adipose tissue. 
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SEKO adipocytes synthesize less TG compared with con-
trol adipocytes, and even more provocatively, they com-
pletely fail to respond to extracellular apoE-containing 
VLDL with increased TG synthesis. In isolated adipocytes, 
 Fig.  5. TG synthesis in freshly isolated mature and cultured adipocytes. Freshly isolated mature and cultured adipocytes of SEKO or control 
mice were prepared as described in the Methods. Cells were incubated with 0.5   Ci/ml [ 14 C]glucose in 0.1% BSA and DMEM with or without 
100   g/ml apoE-containing VLDL for 6 h at 37°C. [ 14 C]TG was separated by TLC, radioactivity of TG spots was estimated by   -counter. Results 
are the mean ± SD of fi ve mice per group (male, 8 weeks old). * P < 0.05; ** P < 0.01 for the difference between control and SEKO mice. 
 Fig.  6. Gene expression in freshly isolated mature adipocytes of 
SEKO mic e . Adipocytes were prepared from the adipose tissue of 
SEKO or control mice. Adipocyte gene expression was analyzed by 
qRT-PCR as described in the Methods. Results are the mean ± SD 
of fi ve mice per group, each run in duplicate. * P < 0.05; ** P < 0.01 
for the difference between control and SEKO mice. 
 DISCUSSION 
 This is the fi rst report of a model in which the conse-
quences of tissue-specifi c reduction of apoE expression 
can be examined without the need for tissue transplanta-
tion. We report that selective reduction of adipose tissue 
apoE, in the presence of normal circulating levels of apoE, 
produces a novel and somewhat unexpected phenotype. 
First, there is a signifi cant improvement in systemic insulin 
sensitivity. Second, the accumulation of lipids in muscle 
and liver is reduced. Third, ATMs are modulated to a non-
infl ammatory phenotype. 
 ApoE, fi rst established as a liver-derived ligand for cell 
surface lipoprotein receptors, is now known to be pro-
duced by numerous cell types with pleiotropic and tissue 
specifi c effects. ApoE production in adipose tissue by adi-
pocytes was fi rst described by Zechner et al. ( 5 ). Subse-
quent studies have shown that apoE production by 
adipocytes is regulated by a number of physiologically rel-
evant factors including PPAR  agonists, infl ammatory cy-
tokines, and organismal nutritional status and diet 
( 10–13 ). In addition, using adipocytes isolated from glob-
ally apoE-defi cient mice, or isolated from adipose tissue 
derived from these mice after transplantation into wild-
type hosts, endogenous adipocyte apoE expression has 
been shown to signifi cantly infl uence adipocyte lipid fl ux 
and gene expression ( 6–8 ). The straightforward interpre-
tation of the results of the above studies however is con-
founded by the exposure of adipose tissue, at some point, 
to the massive hyperlipidemia that is characteristic of 
global apoE defi ciency. The SEKO mouse model used for 
the current study eliminates this confounding issue and 
establishes that when adipose apoE expression is sup-
pressed in the presence of normal circulating levels of 
apoE, adipose tissue mass is reduced, adipocytes are 
smaller and contain fewer lipids, and adipocyte gene ex-
pression is altered. The results in  Fig. 5 demonstrate that 
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reduction could relate directly to changes in systemic insu-
lin action. There were no differences in circulating total 
or HMW -adiponectin levels (not shown) between control 
and SEKO mice, implying that this adipokine is not re-
sponsible for the observed differences in insulin sensitiv-
ity; although a tissue-specifi c role for adiponectin signaling 
cannot be ruled out. 
 We did, however, measure signifi cant differences be-
tween control and SEKO mice in lipid accumulation in 
liver and skeletal muscle. In SEKO mice, lipid content in 
these tissues is signifi cantly reduced. The notion that this 
reduction could contribute to changes in insulin action 
in SEKO mice is consistent with a large body of literature 
suggesting that the lipid content of hepatocytes and skel-
etal muscle modulates their responsiveness to insulin 
( 24–28 ). In addition, we noted an unexpected and pro-
vocative change in adipose tissue inflammatory state 
between control and SEKO mice, with the latter demon-
strating a much less infl ammatory phenotype. That this 
change in adipose tissue inflammatory state could con-
tribute to systemic changes in systemic insulin action be-
tween control and SEKO mice is consistent with an extensive 
literature demonstrating that adipose tissue infl ammation 
we have previously reported that in the absence of endog-
enous apoE expression, adipocytes have reduced inter-
nalization of extracellular free fatty acid and reduced 
receptor-mediated internalization of apoE-containing 
VLDL particles. The latter defect is accounted for primar-
ily by a reduction in adipocyte expression of VLDL recep-
tors ( 8 ). 
 Importantly, the current model uniquely allows the in-
vestigation of a potential systemic impact of reduced adi-
pose tissue apoE expression. The results in  Table 1 and 
 Table 2 show that, at 8 and 12 weeks, respectively, there 
are changes in circulating insulin and glucose levels con-
sistent with better insulin sensitivity in SEKO animals. The 
data in  Fig. 7 confi rm this observation; SEKO mice dem-
onstrate better glucose tolerance and higher insulin effi -
cacy compared with control mice. The systemic changes in 
insulin sensitivity in SEKO mice might be predicted based 
on the reduction in adipose tissue mass and the smaller 
adipocytes measured in these animals, and a number of 
contributing mechanisms can be considered. In prelimi-
nary studies, we measured a reduction in circulating leptin 
levels, consistent with reduced adipose tissue mass, in 
SEKO mice (not shown). However, it is uncertain how this 
 Fig.  7. Glucose and insulin tolerance. Fasted  SEKO or control mice were injected intraperitoneally with 1 g/kg glucose or 0.8 U/kg in-
sulin. Blood glucose levels were measured by tail vein bleeding using an alphaTRACK glucometer. Results are the mean ± SD of fi ve mice 
per group (male, 8 weeks old). * P < 0.05; ** P < 0.01 for the difference between control and SEKO mice. 
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between adipocytes and macrophages that occurs uniquely 
in adipose tissue ( 39 ). 
 One result of using the aP2 promoter to drive expres-
sion of the Cre recombinase in our model is reduced ex-
pression of apoE in both adipocytes and, to a lesser degree, 
in macrophages. This is advantageous in that it leads to a 
more substantial reduction in total adipose tissue apoE, 
where both cell types produce apoE. This, however, does 
not allow an unambiguous assignment of the characteris-
tics of SEKO mice to specifi c reduction in one cell type 
versus the other. The specifi c contribution of macrophage 
and adipocyte apoE in adipose tissue for producing the 
metabolic and infl ammatory phenotype in the SEKO 
model will need to be addressed in the future using adi-
pocyte- or macrophage-specific promoters for the Cre 
recombinase. 
 Although adipose tissue apoE expression is reduced at 
the transcript and protein level in SEKO mice, expression 
is by no means negligible. It is somewhat surprising then 
that the phenotype, with respect to adipocyte lipid fl ux 
and gene expression, is as substantially altered as we re-
port here. Even more surprising is that systemic meta-
bolic changes and adipose tissue infl ammatory differences 
are so evident. These results imply that the adipose tissue 
and systemic phenotype are extremely sensitive to small 
changes in adipose tissue apoE expression. In view of this, 
additional investigation of the mechanisms regulating adi-
pose tissue apoE expression and further investigation of 
the pathways by which this expression infl uences systemic 
metabolic phenotype and adipose tissue infl ammatory 
state will be important.  
has a deleterious effect on systemic insulin action ( 29–
35 ). Consistent with this conclusion, Pownall and col-
leagues recently reported that the adipose tissue of 
globally defi cient apoE mice was less infl ammatory com-
pared with wild-type mice ( 36 ). In that report, globally 
defi cient apoE mice on a high-fat diet remained more 
insulin sensitive than weight-matched wild-type controls 
with lower levels of infl ammatory cytokines in adipose 
tissue and in muscle. The repeated administration of 
apoE-poor VLDL induced adipose tissue infl ammation in 
wild-type, but not globally defi cient, apoE mice. These 
latter results are particularly provocative, as they indicate 
that apoE is necessary to promote adipose tissue infl am-
mation, even in the presence of the marked hyperlipid-
emia that is present in globally defi cient apoE mice. Our 
results establish an important role for apoE produced lo-
cally in adipose tissue, independent of circulating apoE, 
for modulating the adipose tissue infl ammatory state. It 
should be noted that the difference in infl ammatory phe-
notype we have measured in adipose tissue from control 
and SEKO mice may be related to the reduced apoE ex-
pression in either macrophages or adipocytes. Others 
have shown that exogenously added apoE can modulate 
macrophage infl ammatory state but, interestingly, sup-
presses the infl ammatory phenotype ( 37, 38 ). Our re-
sults, however, imply that the expression of apoE in 
adipose tissue promotes an infl ammatory phenotype. 
The difference between the above mentioned observa-
tions could refl ect a functional difference between the 
effect of endogenously expressed compared with addition 
of extracellular apoE, or could result from the cross-talk 
 Fig.  8. Tissue lipid levels. Adipose tissue, liver, muscle, and heart were harvested from SEKO or control mice at 8 weeks of age. Tissue 
lipids were extracted and TG or TC levels were estimated as described in the Methods. Results are the mean ± SD of fi ve mice per group. 
* P < 0.05; ** P < 0.01 for the difference between control and SEKO mice. 
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